Also found in: Medical, Encyclopedia, Wikipedia.
Related to ribonucleotide: Ribonucleotide reductase


 (rī′bō-no͞o′klē-ə-tīd′, -nyo͞o′-)
A nucleotide that contains ribose as its sugar and is a component of RNA.


a nucleotide which contains ribose as its sugar component


(ˌraɪ boʊˈnu kli əˌtaɪd, -ˈnyu-)

an ester, composed of a ribonucleoside and phosphoric acid, that is a constituent of ribonucleic acid.
Mentioned in ?
References in periodicals archive ?
9 The current study was planned to find out the genotype and allelic frequency at C/T-I3 + 17 SNP in CD28 and CD40 Cytadine/Thymadine deoxy ribonucleotide C/T-1 SNP inCD40 in clinically diagnosed GD patients and in their age-match controls.
As a typical example, biologically active substances known as a ribonucleic acid / ribonucleotide extract (RN preparations), derivatives of connective tissue of animals and yeast (Schroeder et al.
sup][2] FDG avidity of NSCLC and ERCC1 and ribonucleotide reductase subunit M1 (RRM1) levels have not been as extensively investigated.
Distribution of genes associated to various molecular functions nucleic acid binding (468) nucleotide binding (420) nucleoside phosphate binding (420) ribonucleotide binding (325) nucleoside binding (305) Note: Table made from pie chart.
A previous investigation explained that the decrease in IL-1[beta] levels with MTX is due to the inhibitory effect of MTX on 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase (ATIC).
Gallic acid inhibits ribonucleotide reductase and cyclooxygenases in human HL-60 promyelocytic leukemia cells.
Analysis of a herpes simplex virus 2 fragment from the open reading frame of the large subunit of ribonucleotide reductase with transcriptional regulatory activity.
Within the 3 minisatellites mentioned above, ORF94 is located between two subunits of ribonucleotide reductase (rr1 and rr2) and has proven to be most useful for analysis of WSSV variability.
Moreover, the U 39 region of the HSV-1 genome codes for a subunit of ribonucleotide reductase called ICP6.
Several possible mechanisms have been reported for the anti-tumor effects of iron chelating agents, including prevention of ribonucleotide reductase activity [20], which is a rate-limiting enzyme in DNA synthesis; inhibition of cell cycle progression by inducing G1/S cell cycle arrest [21]; and inhibition of metastasis via the up-regulation of N-Myc downstream-regulated gene 1 [22].
The following are considered: CDDO-ethyl amide, CDDO-trifluroethylamide, pioglitazone, rosiglitazone, resveratrol, 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), and bezafibrate [129].